INmune Bio Co-Founder and Chief Scientific Officer Mark Lowdell, PhD, Delivers Keynote at CTERP International Conference
April 12, 2018 10:05 ET
|
INmune Bio, Inc.
LA JOLLA, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- INmune Bio, Inc., an immunotherapy company developing therapies that reprogram the patient’s innate immune system to treat cancer, announces...